Publications

Frankenfeld CL. Dietary data processing and analysis: Considerations for microbiome-diet research. Best Practices for Characterization of Diet in Gut Microbiome Research: Focus on Dietary Assessment, Gut Microbiome Committee, ILSI North America, August 20, 2020.

Dronin-Fenton D, Dalvi T, Movva N, Pedersen I, Hansen H, Fryzek J, Mellemgaard A, Rasmussen T, et al. PD-L1 expression and survival in stage III unresectable non-small cell lung cancer patients in Denmark. Abstract #2865, European Society for Medical Oncology (ESMO), Virtual, August 2020.

Loper J, Lewis KH, Rothberg A, Auriemma A, Coburn SL, Cohen SS, Matarese L, Pories WJ, Jiang X, Periman S, Ard JD. Weight change in participants completing meal replacement program is related to level of engagement. Obesity Week Conference, Virtual, 2020.

Dean R, Arjunji R, Awano H, Igarash A^, Tanaka A, Jensen IS, Cyr PL, Miller B, et al. Cost-effectiveness of onasemnogene abeparvocec (ZOLGENSMA) for spinal muscular atrophy type 1 against nusinersen in Japan. ISPOR 25th Annual International Meeting, Orlando FL, 2020.

Sacks NC, Healey B, Cyr PL, Graham R. Economic burden of X-linked myotubular myopathy (XLMTM) by ventilation status. ISPOR 25th Annual International Meeting, Orlando FL, 2020.

Wallace TC, Frankenfeld CL, Frei B, Shah A, Yu C-R, van Klinken J-W, Adeleke M. Multivitamin use is associated with increased micronutrient intake and biomarkers and decreased prevalence of inadequacies in middle-aged and older adults. Abstract nzaa061_129, Nutrition 2020. Curr Dev Nutr 4(Sup 2)nzaa061_129; doi: 10.1093/cdn/nzaa061_129. Virtual, 2020.

Dean R, Miller B, Arjunji R, Awano H, Igarashi A, Tanaka S, Feltner DE, Sproule DM, Jensen I, Dabbous O. 2020. Abstract PMU36: Cost-utility analysis of single dose gene-replacement therapy for spinal muscular atrophy type 1 compared to chronic nusinersen treatment in Japan. Value in Health 23(Sup 1):S239; doi: 10.1016/j.val.2020.04.810.

Hathway J, Miller-Wilson L, Jensen I, Ozbay B, Regan C, Yao W, et al. Budget impact of improving adherence to colorectal cancer screening. Abstract PCN148, ISPOR 2020.

Hathway J, Miller-Wilson L, Jensen I, Ozbay B, Regan C, Yao W, et al. The impact of increasing mt-sDNA use among colorectal cancer screeners in a US employer population. Abstract PCN145, ISPOR 2020.

Miller B, Jensen I, Dean R, Slocomb T, James ES, Beggs AH. 2020. Abstract PRO77: Health resource use in patients with x-linked myotubular myopathy (XLMTM): Data from the RECENSUS study. Value in Health 23(Sup 1):S342; doi: 10.1016/j.jval.2020.04.1298.